[PHARMA] YoY Quarter Result on 30-Jun-2017 [#2]

Stock

[PHARMA] PHARMANIAGA BHD

Announcement Date

16-Aug-2017

Admission Sponsor

Sponsor

Financial Year

31-Dec-2017

Quarter

30-Jun-2017 [#2]

Profit Trend

QoQ- -49.69%

YoY- -36.51%

Quarter Report

PHARMA's Financial Summary

View:

Show?

YoY %

Horiz. %

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Quarter Result
Revenue	645,763	601,890	582,729	517,967	531,796	512,845	525,072	3.50%
YoY %	7.29%	3.29%	12.50%	-2.60%	3.70%	-2.33%	-	-
Horiz. %	122.99%	114.63%	110.98%	98.65%	101.28%	97.67%	100.00%	-
PBT	14,326	12,481	11,970	10,150	21,487	25,056	24,622	-8.62%
YoY %	14.78%	4.27%	17.93%	-52.76%	-14.24%	1.76%	-	-
Horiz. %	58.18%	50.69%	48.62%	41.22%	87.27%	101.76%	100.00%	-
Tax	-4,719	-3,219	-6,204	-399	-5,846	-8,414	-8,665	-9.62%
YoY %	-46.60%	48.11%	-1,454.89%	93.17%	30.52%	2.90%	-	-
Horiz. %	54.46%	37.15%	71.60%	4.60%	67.47%	97.10%	100.00%	-
NP	9,607	9,262	5,766	9,751	15,641	16,642	15,957	-8.10%
YoY %	3.72%	60.63%	-40.87%	-37.66%	-6.01%	4.29%	-	-
Horiz. %	60.21%	58.04%	36.13%	61.11%	98.02%	104.29%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
NP to SH	9,979	9,281	5,394	9,520	14,995	16,217	15,975	-7.53%
YoY %	7.52%	72.06%	-43.34%	-36.51%	-7.54%	1.51%	-	-
Horiz. %	62.47%	58.10%	33.77%	59.59%	93.87%	101.51%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Tax Rate	32.94%	25.79%	51.83%	3.93%	27.21%	33.58%	35.19%	-
YoY %	27.72%	-50.24%	1,218.83%	-85.56%	-18.97%	-4.58%	-	-
Horiz. %	93.61%	73.29%	147.29%	11.17%	77.32%	95.42%	100.00%	-
Total Cost	636,156	592,628	576,963	508,216	516,155	496,203	509,115	3.77%
YoY %	7.34%	2.72%	13.53%	-1.54%	4.02%	-2.54%	-	-
Horiz. %	124.95%	116.40%	113.33%	99.82%	101.38%	97.46%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Net Worth	357,891	518,564	519,642	542,147	524,177	528,477	502,293	-5.48%
YoY %	-30.98%	-0.21%	-4.15%	3.43%	-0.81%	5.21%	-	-
Horiz. %	71.25%	103.24%	103.45%	107.93%	104.36%	105.21%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Dividend
Div	6,530	6,514	10,392	10,376	12,949	18,134	10,356	-7.39%
YoY %	0.25%	-37.32%	0.15%	-19.87%	-28.59%	75.11%	-	-
Horiz. %	63.06%	62.90%	100.35%	100.19%	125.04%	175.11%	100.00%	-
Div Payout %	65.45%	70.19%	192.67%	108.99%	86.36%	111.82%	64.83%	-
YoY %	-6.75%	-63.57%	76.78%	26.20%	-22.77%	72.48%	-	-
Horiz. %	100.96%	108.27%	297.19%	168.12%	133.21%	172.48%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Equity
Net Worth	357,891	518,564	519,642	542,147	524,177	528,477	502,293	-5.48%
YoY %	-30.98%	-0.21%	-4.15%	3.43%	-0.81%	5.21%	-	-
Horiz. %	71.25%	103.24%	103.45%	107.93%	104.36%	105.21%	100.00%	-
NOSH	261,705	261,229	259,821	259,400	258,981	259,057	258,914	0.17%
YoY %	0.18%	0.54%	0.16%	0.16%	-0.03%	0.06%	-	-
Horiz. %	101.08%	100.89%	100.35%	100.19%	100.03%	100.06%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Ratio Analysis
NP Margin	1.49%	1.54%	0.99%	1.88%	2.94%	3.25%	3.04%	-
YoY %	-3.25%	55.56%	-47.34%	-36.05%	-9.54%	6.91%	-	-
Horiz. %	49.01%	50.66%	32.57%	61.84%	96.71%	106.91%	100.00%	-
ROE	2.79%	1.79%	1.04%	1.76%	2.86%	3.07%	3.18%	-
YoY %	55.87%	72.12%	-40.91%	-38.46%	-6.84%	-3.46%	-	-
Horiz. %	87.74%	56.29%	32.70%	55.35%	89.94%	96.54%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Per Share
RPS	247.20	230.98	224.28	199.68	205.34	197.97	202.80	3.35%
YoY %	7.02%	2.99%	12.32%	-2.76%	3.72%	-2.38%	-	-
Horiz. %	121.89%	113.90%	110.59%	98.46%	101.25%	97.62%	100.00%	-
EPS	3.82	3.56	2.08	3.67	5.79	6.26	6.17	-7.67%
YoY %	7.30%	71.15%	-43.32%	-36.61%	-7.51%	1.46%	-	-
Horiz. %	61.91%	57.70%	33.71%	59.48%	93.84%	101.46%	100.00%	-
DPS	2.50	2.50	4.00	4.00	5.00	7.00	4.00	-7.52%
YoY %	0.00%	-37.50%	0.00%	-20.00%	-28.57%	75.00%	-	-
Horiz. %	62.50%	62.50%	100.00%	100.00%	125.00%	175.00%	100.00%	-
NAPS	1.37	1.99	2.00	2.09	2.024	2.04	1.94	-5.62%
YoY %	-31.16%	-0.50%	-4.31%	3.26%	-0.78%	5.15%	-	-
Horiz. %	70.62%	102.58%	103.09%	107.73%	104.33%	105.15%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Adjusted Per Share Value based on latest NOSH - 259,400
RPS	44.81	41.76	40.43	35.94	36.90	35.58	36.43	3.50%
YoY %	7.30%	3.29%	12.49%	-2.60%	3.71%	-2.33%	-	-
Horiz. %	123.00%	114.63%	110.98%	98.65%	101.29%	97.67%	100.00%	-
EPS	0.69	0.64	0.37	0.66	1.04	1.13	1.11	-7.61%
YoY %	7.81%	72.97%	-43.94%	-36.54%	-7.96%	1.80%	-	-
Horiz. %	62.16%	57.66%	33.33%	59.46%	93.69%	101.80%	100.00%	-
DPS	0.45	0.45	0.72	0.72	0.90	1.26	0.72	-7.52%
YoY %	0.00%	-37.50%	0.00%	-20.00%	-28.57%	75.00%	-	-
Horiz. %	62.50%	62.50%	100.00%	100.00%	125.00%	175.00%	100.00%	-
NAPS	0.2483	0.3598	0.3606	0.3762	0.3637	0.3667	0.3485	-5.48%
YoY %	-30.99%	-0.22%	-4.15%	3.44%	-0.82%	5.22%	-	-
Horiz. %	71.25%	103.24%	103.47%	107.95%	104.36%	105.22%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Price Multiplier on Financial Quarter End Date
Date	30/06/20	28/06/19	29/06/18	30/06/17	30/06/16	30/06/15	30/06/14	-
Price	2.22	2.84	2.88	4.58	5.50	7.13	4.61	-
P/RPS	0.90	1.23	1.28	2.29	2.68	3.60	2.27	-14.27%
YoY %	-26.83%	-3.91%	-44.10%	-14.55%	-25.56%	58.59%	-	-
Horiz. %	39.65%	54.19%	56.39%	100.88%	118.06%	158.59%	100.00%	-
P/EPS	58.12	79.74	138.73	124.80	94.99	113.90	74.72	-4.09%
YoY %	-27.11%	-42.52%	11.16%	31.38%	-16.60%	52.44%	-	-
Horiz. %	77.78%	106.72%	185.67%	167.02%	127.13%	152.44%	100.00%	-
EY	1.72	1.25	0.72	0.80	1.05	0.88	1.34	4.24%
YoY %	37.60%	73.61%	-10.00%	-23.81%	19.32%	-34.33%	-	-
Horiz. %	128.36%	93.28%	53.73%	59.70%	78.36%	65.67%	100.00%	-
DY	1.13	0.88	1.39	0.87	0.91	0.98	0.87	4.45%
YoY %	28.41%	-36.69%	59.77%	-4.40%	-7.14%	12.64%	-	-
Horiz. %	129.89%	101.15%	159.77%	100.00%	104.60%	112.64%	100.00%	-
P/NAPS	1.62	1.43	1.44	2.19	2.72	3.50	2.38	-6.20%
YoY %	13.29%	-0.69%	-34.25%	-19.49%	-22.29%	47.06%	-	-
Horiz. %	68.07%	60.08%	60.50%	92.02%	114.29%	147.06%	100.00%	-

	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	30/06/14	CAGR
Price Multiplier on Announcement Date
Date	19/08/20	23/08/19	17/08/18	16/08/17	19/08/16	17/08/15	21/08/14	-
Price	4.42	2.66	3.11	4.19	5.62	5.65	4.62	-
P/RPS	1.79	1.15	1.39	2.10	2.74	2.85	2.28	-3.94%
YoY %	55.65%	-17.27%	-33.81%	-23.36%	-3.86%	25.00%	-	-
Horiz. %	78.51%	50.44%	60.96%	92.11%	120.18%	125.00%	100.00%	-
P/EPS	115.71	74.69	149.80	114.17	97.06	90.26	74.88	7.51%
YoY %	54.92%	-50.14%	31.21%	17.63%	7.53%	20.54%	-	-
Horiz. %	154.53%	99.75%	200.05%	152.47%	129.62%	120.54%	100.00%	-
EY	0.86	1.34	0.67	0.88	1.03	1.11	1.34	-7.11%
YoY %	-35.82%	100.00%	-23.86%	-14.56%	-7.21%	-17.16%	-	-
Horiz. %	64.18%	100.00%	50.00%	65.67%	76.87%	82.84%	100.00%	-
DY	0.57	0.94	1.29	0.95	0.89	1.24	0.87	-6.79%
YoY %	-39.36%	-27.13%	35.79%	6.74%	-28.23%	42.53%	-	-
Horiz. %	65.52%	108.05%	148.28%	109.20%	102.30%	142.53%	100.00%	-
P/NAPS	3.23	1.34	1.56	2.00	2.78	2.77	2.38	5.21%
YoY %	141.04%	-14.10%	-22.00%	-28.06%	0.36%	16.39%	-	-
Horiz. %	135.71%	56.30%	65.55%	84.03%	116.81%	116.39%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 0 of 0 comments

Featured Posts

Moomoo MY

Open a Moomoo Account Today and Win an Apple iPad Air*!

Latest Videos

MQ Market Updates - 29 April 2024

MQ Trader

MQ Trading Signals

2024-04-29 15:20:00

EMA 5

5 Mins

SELL

2024-04-29 15:15:00

ADX

5 Mins

SELL

2024-04-29 15:10:00

EMA 5

10 Mins

SELL

2024-04-29 15:05:00

EMA 5

5 Mins

BUY

2024-04-29 15:05:00

ADX

5 Mins

BUY

More Trading Signals

Apps

MQ Chat

Send individual or group chats with anyone on i3investor

MQ Trader

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

MQdemy

Online learning and teaching marketplace

Hot Stocks Today >

TASCO

TASCO BERHAD

1000

YTLPOWR

YTL POWER INTERNATIONAL BHD

480

MYEG

MY E.G. SERVICES BHD

366

YTL

YTL CORPORATION BHD

327

PTRANS

PERAK TRANSIT BERHAD

323

MPI

MALAYSIAN PACIFIC INDUSTRIES

315

HLIND

HONG LEONG INDUSTRIES BHD

298

CAPITALA

CAPITAL A BERHAD

251

TOPGLOV

TOP GLOVE CORPORATION BHD

210

GENM

GENTING MALAYSIA BERHAD

198

Daily Stocks

HSI-CVZ

0.175

+0.005

307,435,200

MYEG

0.91

-0.005

214,978,300

HSI-HUS

0.085

-0.005

205,959,100

INIX-OR

0.02

0.00

141,839,900

BPURI

0.075

0.00

98,691,600

TWL

0.03

0.00

93,648,100

EDUSPEC-OR

0.005

0.00

75,002,700

TOPGLOV

0.885

+0.055

68,117,900

CAPITALA

0.79

+0.055

66,923,500

YTL

3.20

+0.17

62,897,000

More active Stocks

APOLLO

6.99

+0.50

174,100

MPI

30.00

+0.50

78,800

HUMEIND-LA

3.88

+0.38

9,800

YTLPOWR

4.79

+0.37

56,658,400

CHINHIN

5.30

+0.30

239,300

KLK

23.20

+0.20

3,025,900

YTLPOWR-C30

1.76

+0.20

3,000

HSI-CXD

1.27

+0.18

610,000

YTLPOWR-C36

1.00

+0.175

586,200

YTL

3.20

+0.17

62,897,000

More gainer Stocks

HSI-HS6

0.815

-0.395

300,000

DLADY

33.82

-0.38

19,500

NESTLE

126.90

-0.30

131,200

AIRPORT

9.94

-0.26

5,042,300

HSI-HS4

0.245

-0.235

31,200

HSI-HUZ

0.50

-0.22

50,500

KLCC

7.52

-0.19

38,700

ORIENT

6.97

-0.18

1,220,900

HSI-HS3

0.43

-0.175

14,100

MALPAC

0.905

-0.125

5,000

More loser Stocks

Featured Advertisers / Partners

Top Brokers >

AmEquities

Affin Hwang

Rakuten Trade

Hong Leong Bank

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....

Read More